IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $164,398,120 | +7880.5% | 8,712,142 | +1913.5% | 0.49% | +6012.5% |
| Q1 2022 | $2,060,000 | -49.2% | 432,678 | -39.5% | 0.01% | -55.6% |
| Q3 2021 | $4,052,000 | +232.1% | 714,700 | +58.8% | 0.02% | +200.0% |
| Q1 2019 | $1,220,000 | -93.5% | 450,000 | -88.5% | 0.01% | -93.4% |
| Q4 2018 | $18,741,000 | -71.4% | 3,904,299 | -43.6% | 0.09% | -66.3% |
| Q3 2018 | $65,559,000 | +227.7% | 6,922,765 | +236.7% | 0.27% | +237.5% |
| Q2 2018 | $20,004,000 | – | 2,055,933 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |